XML 72 R4.htm IDEA: XBRL DOCUMENT v3.19.3
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
 1 Months Ended 2 Months Ended 3 Months Ended 8 Months Ended 9 Months Ended
Sep. 30, 2018
Aug. 27, 2018
Sep. 30, 2019
Aug. 27, 2018
Sep. 30, 2019
Successor          
Revenues $ 672,844   $ 2,909,282   $ 8,413,667
Cost of goods sold 93,027   285,164   909,333
Gross profit 579,817   2,624,118   7,504,334
Operating expenses          
Selling, general and administrative expense 551,727   3,315,575   8,649,186
Depreciation and amortization 50   45,762   72,644
Bad debt expense 0   60,000   60,000
Total operating expenses 551,777   3,421,337   8,781,830
Operating income (loss) 28,040   (797,219)   (1,277,496)
Other income / (expense)          
Other income (expense) 23,367   0   145
Interest expense 0   (46,014)   (80,925)
Total other income / (expense) 23,367   (46,014)   (80,780)
Net income (loss) 51,407   (843,233)   (1,358,276)
Less: net income (loss) attributable to noncontrolling interest 0   (6,257)   (7,311)
Net income (loss) attributable to Sanara MedTech, Inc. 51,407   (836,976)   (1,350,965)
Series C preferred stock dividends 0   0   0
Series C Preferred Stock inducement dividends 0   0   0
Net loss attributable to common stockholders $ 51,407   $ (836,976)   $ (1,350,965)
Basic income per share of common stock $ 0.00   $ (0.35)   $ (0.78)
Diluted income per share of common Stock $ 0.00   $ (0.35)   $ (0.78)
Weighted average number of common shares outstanding basic 0   2,366,181   1,724,848
Weighted average number of common shares outstanding diluted 0   2,366,181   1,724,848
Predecessor          
Revenues   $ 1,549,675   $ 5,773,552  
Cost of goods sold   111,809   480,703  
Gross profit   1,437,866   5,292,849  
Operating expenses          
Selling, general and administrative expense   1,423,989   5,126,650  
Depreciation and amortization   14,349   56,425  
Bad debt expense   0   12,558  
Total operating expenses   1,438,338   5,195,633  
Operating income (loss)   (472)   97,216  
Other income / (expense)          
Other income (expense)   268   570  
Interest expense   0   (60,608)  
Total other income / (expense)   268   (60,038)  
Net income (loss)   (204)   37,178  
Less: net income (loss) attributable to noncontrolling interest   0   0  
Net income (loss) attributable to Sanara MedTech, Inc.   (204)   37,178  
Series C preferred stock dividends   0   (28,061)  
Series C Preferred Stock inducement dividends   0   (103,197)  
Net loss attributable to common stockholders   $ (204)   $ (94,080)  
Basic income per share of common stock   $ 0.00   $ (0.05)  
Diluted income per share of common Stock   $ 0.00   $ (0.05)  
Weighted average number of common shares outstanding basic   2,366,429   2,068,941  
Weighted average number of common shares outstanding diluted   2,366,429   2,068,941